Fred Schwarzer - May 13, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
CEO and President, Director
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
May 13, 2022
Transactions value $
$5,125
Form type
4
Date filed
5/17/2022, 06:58 PM
Previous filing
Mar 17, 2022
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $5.13K +414 +1.19% $12.38 35.3K May 13, 2022 Direct F1
holding IGMS Common Stock 197K May 13, 2022 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.